Our findings, aligned with our previous study highlighting the role of PAR2 in LPS-induced sickness behaviour, suggest that PAR2 activation may be a novel model for examining behavioural changes associated with sickness and depression-like behaviour and that its inhibition may ameliorate these changes. Here, F2RL1 is linked to depressive symptom measurement.